Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Microarrays help to discover how genomic copy number changes or translocations occur in cell division

Agilent Technologies Europe : 17 January, 2008  (New Product)
For the first time researchers at Baylor College of Medicine (BCM), Houston, Texas, have observed a unique way that DNA additions or deletions associated with a wide range of diseases are introduced in genes during cell division.
The research findings are published in the current issue of the journal Cell. These types of ‘errors’ have been associated with Alzheimer's, Parkinson's, Potocki-Lupski Syndrome and other developmental and neurological disorders.
Custom Agilent oligonucleotide comparative genomic hybridisation microarrays played a key role in the discovery.

The article entitled A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders, describes a newly discovered mechanism for human genomic disorders called replication Fork Stalling and Template Switching (FoSTes) in which segments of DNA are added or deleted in previously unexpected locations during replication.

'We're very pleased to provide tools with the flexibility, sensitivity and resolution to enable this breakthrough research,' said Condie Carmack, PhD, marketing manager, Agilent. 'The Baylor team needed total control over the sequences on their microarrays as well as very high sensitivity and precision to make this research work. Our SurePrint in-situ synthesis platform is particularly well-suited for this type of work.'

'The Agilent microarrays were essential in enabling us to elucidate this novel mechanism,' said BCM's James R. Lupski, MD, PhD, Cullen professor of molecular and human genetics, the senior investigator of this report.

When a DNA addition or deletion occurs in the wrong place, a genomic-based disorder like Pelizaeus-Merzbacher disease (PMD) can occur. PMD is a progressive degenerative disorder of the central nervous system in which motor abilities and intellectual function deteriorate. This X-linked neurodevelopment disorder affects males and can have particularly devastating consequences.

Jennifer Lee, PhD, the lead author and a member of the team, was studying PMD and found genomic changes that previous theories about DNA recombination did not explain. In some places, extra genetic material was found in the middle of another duplication. Baylor's FoSTeS mechanism explains this, Lupski points out.

Lupski pioneered the emerging field of copy number variation (CNV) in the early 1990s in the quest to understand genetic variation and the multiple molecular mechanism for disease. Now, he and his colleagues have discovered that the DNA replication process can stall, and sometimes, switch to a different ‘template’ rather than restarting in the same place. In addition to disease research, Lupski says the FoSTeS mechanism could also play an important role in studies probing human evolution.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo